Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

James Passin Insider Profile

4 Followers

James Passin, Chief Executive Officer, Ten Percent Owner at BioVaxys Technology, holds 3.56M shares in BioVaxys Technology (Ticker: BVAXF), holds 0.00 shares in St-Georges Platinum and Base Metals (Ticker: TSE:SX), holds 3.05M shares in Mindset Pharma Inc. (Ticker: TSE:MSET). Most recently, James Passin Bought ― shares of BioVaxys Technology on Nov 21, 2025 for an estimated value of $252.38K.

James Passin's Trading History

BVAXFBioVaxys Technology		Nov 21, 2025Chief Executive Officer, Ten Percent OwnerInformative Buy252.38K$320.47K
SXSt-Georges Platinum and Base Metals		Apr 14, 2025DirectorUninformative Sell―C$0.00
MSETMindset Pharma Inc.		Feb 01, 2023―Uninformative Sell24.99KC$2.25M
SHIFFShiftCarbon		Jan 05, 2023Director, Ten Percent OwnerUninformative Buy14.28K$85.94K
EDENEden Empire Inc		Mar 13, 2019―Informative Sell10.09KC$0.00
VEL.HVanoil Energy		Mar 19, 2014―Uninformative Sell―C$56.30K
GSVRGuanajuato Silver Company		Nov 19, 2010DirectorInformative Buy―C$1.26M
GAXFFRosehearty Energy		―――$0.00
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

James Passin insider profile FAQ

What is the percentage of profitable transactions made by James Passin?
The percentage of profitable transactions made by James Passin is 44%.
What is the average return per transaction made by James Passin?
The average return per transaction made by James Passin is 43.10%.
What stocks does James Passin hold?
James Passin holds: BVAXF, TSE:SX, TSE:GSVR, TSE:VEL.H, GAXFF, SHIFF, TSE:MSET, TSE:EDEN stocks.
What was James Passin’s latest transaction?
James Passin’s latest transaction was an Informative Buy of $252.38K.
What was James Passin's most profitable transaction?
James Passin’s most profitable transaction was an Informative Buy of SHIFF stock on June 26, 2019. The return on the trade was 255.40%.
What is James Passin's role in BioVaxys Technology?
James Passin's role in BioVaxys Technology is Chief Executive Officer, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.